| 000 | 01813 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514002254.0 | ||
| 264 | 0 | _c20010719 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMatsuda, T | |
| 245 | 0 | 0 |
_aSEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cJul 2001 |
||
| 300 |
_a249-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAniline Compounds _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 |
_aAstrocytes _xdrug effects |
| 650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
| 650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
| 650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 |
_aIon Channels _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aIon Transport _xdrug effects |
| 650 | 0 | 4 |
_aPhenyl Ethers _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReperfusion Injury _xdrug therapy |
| 650 | 0 | 4 |
_aSodium-Calcium Exchanger _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aThiourea _xanalogs & derivatives |
| 700 | 1 | _aArakawa, N | |
| 700 | 1 | _aTakuma, K | |
| 700 | 1 | _aKishida, Y | |
| 700 | 1 | _aKawasaki, Y | |
| 700 | 1 | _aSakaue, M | |
| 700 | 1 | _aTakahashi, K | |
| 700 | 1 | _aTakahashi, T | |
| 700 | 1 | _aSuzuki, T | |
| 700 | 1 | _aOta, T | |
| 700 | 1 | _aHamano-Takahashi, A | |
| 700 | 1 | _aOnishi, M | |
| 700 | 1 | _aTanaka, Y | |
| 700 | 1 | _aKameo, K | |
| 700 | 1 | _aBaba, A | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 298 _gno. 1 _gp. 249-56 |
|
| 999 |
_c11338766 _d11338766 |
||